Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RCT comparing the levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation in women suffering from menorrhagia (MIRA)

Trial Profile

RCT comparing the levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation in women suffering from menorrhagia (MIRA)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Levonorgestrel (Primary)
  • Indications Menorrhagia
  • Focus Therapeutic Use
  • Acronyms MIRA
  • Most Recent Events

    • 10 Jul 2021 Results evaluating the costs and non-inferiority of a strategy starting with the LNG-IUS compared to endometrial ablation in the treatment of heavy menstrual bleeding, published in the BJOG: An International Journal of Obstetrics and Gynaecology
    • 11 Aug 2020 Status changed from not yet recruiting to completed, as per results published in the American Journal of Obstetrics and Gynecology
    • 11 Aug 2020 Primary endpoint (blood loss at 24 months) has not been met, as per Results published in the American Journal of Obstetrics and Gynecology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top